Готові списки джерел за темами / Intravenous Infusion of Helixor®

Зміст

  1. Статті в журналах
  2. Дисертації
  3. Книги
  4. Частини книг
  5. Тези доповідей конференцій
  6. Звіти організацій

Добірка наукової літератури з теми "Intravenous Infusion of Helixor®"

Автор: Grafiati
Опубліковано: 3 червня 2025
Оновлено: 31 липня 2025

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Intravenous Infusion of Helixor®".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Intravenous Infusion of Helixor®"

1

Yong-Il, Ji. "INTRAVENOUS APPLICATION OF HELIXOR® IN GYNECOLOGICAL ONCOLOGY: IS IT SAFE?" International Journal of Research - Granthaalayah 5, no. 10 (2017): 307–12. https://doi.org/10.5281/zenodo.1043407.

Повний текст джерела
Анотація:
<strong>Background:</strong> Traditional mistletoe (Viscum album L.) therapy has been frequently used in patients with cancer in Europe. The different mistletoe formulations available for oncological use are Iscador®, Iscucin®, AbnovaViscum®, and Lektinol®, as well as Helixor®, which may improve therapeutic outcomes following intravenous (i.v.) administration and therefore, is becoming more commonly used. <strong>Method:</strong> I conducted an observational study in four different University Hospital Centers and the frequency of adverse drug reactions (ADRs) induced by the i.v. infusion of He
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Ji, Yong-Il. "INTRAVENOUS APPLICATION OF HELIXOR® IN GYNECOLOGICAL ONCOLOGY: IS IT SAFE?" International Journal of Research -GRANTHAALAYAH 5, no. 10 (2017): 307–12. http://dx.doi.org/10.29121/granthaalayah.v5.i10.2017.2306.

Повний текст джерела
Анотація:
Background: Traditional mistletoe (Viscum album L.) therapy has been frequently used in patients with cancer in Europe. The different mistletoe formulations available for oncological use are Iscador®, Iscucin®, AbnovaViscum®, and Lektinol®, as well as Helixor®, which may improve therapeutic outcomes following intravenous (i.v.) administration and therefore, is becoming more commonly used.&#x0D; Method: I conducted an observational study in four different University Hospital Centers and the frequency of adverse drug reactions (ADRs) induced by the i.v. infusion of Helixor® was determined.&#x0D;
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Lederer, Ann-Kathrin, Sabine Rieger, Michael Schink, and Roman Huber. "Pharmakokinetics of Mistletoe Lectins after Intravenous Application of a Mistletoe Product in Healthy Subjects." Pharmaceuticals 17, no. 3 (2024): 278. http://dx.doi.org/10.3390/ph17030278.

Повний текст джерела
Анотація:
Mistletoe lectins (ML) have cytotoxic and immunomodulating properties, and subcutaneously applied mistletoe products (MP) containing ML have approval for supportive cancer treatment. MP are also given off-label intravenously, but data about pharmacokinetics are widely lacking. Therefore, the aim of our phase I trial was to evaluate the pharmacokinetics and safety of intravenously applied natural ML. Initially, 12 healthy male volunteers were planned to receive a single infusion of 2000 mg Helixor® P. We had to terminate the study prematurely after the inclusion of eight subjects due to elevati
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Steele, Megan L., Jan Axtner, Antje Happe, Matthias Kröz, Harald Matthes, and Friedemann Schad. "Safety of Intravenous Application of Mistletoe (Viscum albumL.) Preparations in Oncology: An Observational Study." Evidence-Based Complementary and Alternative Medicine 2014 (2014): 1–10. http://dx.doi.org/10.1155/2014/236310.

Повний текст джерела
Анотація:
Background. Traditional mistletoe therapy in cancer patients involves subcutaneous applications ofViscum albumL. preparations, with doses slowly increasing based on patient responses. Intravenous infusion of high doses may improve therapeutic outcomes and is becoming more common. Little is known about the safety of this “off-label” application of mistletoe.Methods. An observational study was performed within the Network Oncology. Treatment with intravenous mistletoe applications is described. The frequency of adverse drug reactions (ADRs) to intravenous mistletoe applications was calculated an
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Paller, Channing J., Lin Wang, Wei Fu, et al. "Abstract 1600: Phase I trial of intravenous mistletoe extract in advanced cancer." Cancer Research 83, no. 7_Supplement (2023): 1600. http://dx.doi.org/10.1158/1538-7445.am2023-1600.

Повний текст джерела
Анотація:
Abstract Purpose: Mistletoe extract is widely used in cancer patients to support therapy and to improve quality of life (QoL). However, its use is controversial due to suboptimal trials and a lack of data supporting its intravenous administration. Patients and Methods: This phase I trial of intravenous Mistletoe (Helixor M) aimed to determine the recommended phase 2 dosing and to evaluate safety. Solid tumor patients progressing on at least one line of chemotherapy received escalating doses of Helixor M three times a week. Assessments were also made of tumor marker kinetics and QoL. Results: T
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Nahata, Milap C. "Intravenous Infusion Conditions." Clinical Pharmacokinetics 24, no. 3 (1993): 221–29. http://dx.doi.org/10.2165/00003088-199324030-00004.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Leggett, Annie. "Intravenous infusion pumps." Nursing Standard 4, no. 28 (1990): 24–26. http://dx.doi.org/10.7748/ns.4.28.24.s37.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Luke, Julia, and Janice Middleton. "Intravenous infusion controllers." Nursing Standard 4, no. 29 (1990): 30–32. http://dx.doi.org/10.7748/ns.4.29.30.s33.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Soto, G., M. Naranjo González, and F. Calero. "Intravenous lidocaine infusion." Revista Española de Anestesiología y Reanimación (English Edition) 65, no. 5 (2018): 269–74. http://dx.doi.org/10.1016/j.redare.2018.01.015.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Holzman, Robert S. "Intravenous Infusion Equipment." International Anesthesiology Clinics 30, no. 3 (1992): 35–50. http://dx.doi.org/10.1097/00004311-199230030-00003.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Дисертації з теми "Intravenous Infusion of Helixor®"

1

Sjöstrand, Fredrik. "Volume kinetics of glucose solutions given by intravenous infusion /." Stockholm, 2005. http://diss.kib.ki.se/2005/91-7140-235-7/.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Peña, Kristen Helen. "Characterization of an oxygen suspension used for intravenous infusion." Thesis, Massachusetts Institute of Technology, 2012. http://hdl.handle.net/1721.1/75714.

Повний текст джерела
Анотація:
Thesis (S.B.)--Massachusetts Institute of Technology, Dept. of Mechanical Engineering, 2012.<br>Cataloged from PDF version of thesis.<br>Includes bibliographical references (p. 45).<br>Oxygenated fluid mixture can be used to treat critically ill patients suffering from asphyxia, lung injury, and cardiac arrest. This oxygenated fluid delivered intravenously re-oxygenates the bloodstream, allowing for more time to resuscitate a patient before they suffer brain and/or organ damage. The concentration of the mixture is crucial for treatment as it affects the viscosity of the fluid, which in turn af
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Ohmes, Cameon. "The disposition of lidocaine during a 6-hour intravenous infusion to young foals." Thesis, Kansas State University, 2014. http://hdl.handle.net/2097/18832.

Повний текст джерела
Анотація:
Master of Science<br>Department of Clinical Sciences<br>Elizabeth Davis<br>Differences in pharmacokinetics and drug disposition exist between young and adult animals which become especially important for drugs with a narrow therapeutic index. While the pharmacokinetics and plasma concentrations of intravenous lidocaine have been studied in adult horses, determination of the disposition in foals is necessary before appropriate clinical use can be determined. This study examined the disposition of intravenous lidocaine in healthy (phase I) and hospitalized (phase II) foals. Phase I consisted of
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Zacchini, Federico <1986&gt. "Histological Study on Double Line of Intravenous Tacrolimus Infusion in Sla Defined Pig Model." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2016. http://amsdottorato.unibo.it/7336/1/Zacchini_Federico_tesi.pdf.

Повний текст джерела
Анотація:
The immunosuppressive therapy still remains the only therapeutic strategy to control excessive immune activation following renal transplantation, but remain the problems related to excessive immunosuppression and in particular the toxicity due to high doses of immunosuppressive drugs such as calcineurin inhibitors. The present study has the aim of documenting, in a porcine animal model, the histological damage from calcineurin inhibitors using incremental doses of Tacrolimus, achieved in a limited amount of time, until it reaches toxic blood concentrations. We perform the study under different
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Zacchini, Federico <1986&gt. "Histological Study on Double Line of Intravenous Tacrolimus Infusion in Sla Defined Pig Model." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2016. http://amsdottorato.unibo.it/7336/.

Повний текст джерела
Анотація:
The immunosuppressive therapy still remains the only therapeutic strategy to control excessive immune activation following renal transplantation, but remain the problems related to excessive immunosuppression and in particular the toxicity due to high doses of immunosuppressive drugs such as calcineurin inhibitors. The present study has the aim of documenting, in a porcine animal model, the histological damage from calcineurin inhibitors using incremental doses of Tacrolimus, achieved in a limited amount of time, until it reaches toxic blood concentrations. We perform the study under different
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Beths, Thierry. "Total intravenous anaesthesia in dogs : development of a target controlled infusion (TCI) scheme for propofol." Thesis, University of Glasgow, 2008. http://theses.gla.ac.uk/354/.

Повний текст джерела
Анотація:
The aim of this work was to develop a propofol (PPF) based Total Intravenous Anaesthesia (TIVA) technique to be used in dogs by veterinary surgeons in practice. As PPF is a poor analgesic agent, this work also looked into the development of a co-infusion scheme for the potent alpha2-adrenoceptor agonist medetomidine (MED) and its active enantiomer dexmedetomidine (DEX). The study was divided into 4 phases. In phase one, canine PPF pharmacokinetic (PK) parameters, derived from previous studies reported in the literature, were incorporated to a Target Controlled Infusion (TCI) system. This appro
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Craig, R. P. "The modification of the metabolic response to injury by the infusion of different intravenous substrates." Thesis, University of Newcastle Upon Tyne, 1986. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.375582.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Debertolis, Letizia [Verfasser]. "Effects of an intravenous infusion of Escherichia coli lipopolysaccharide in early pregnant dairy cattle / Letizia Debertolis." Hannover : Bibliothek der Tierärztlichen Hochschule Hannover, 2015. http://d-nb.info/1073847209/34.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Lawrence, Louann W. Delclos George L. "The effectiveness of a needleless intravenous system in prevention of percutaneous injury in two hospitals /." See options below, 1994. http://proquest.umi.com/pqdweb?did=741832391&sid=1&Fmt=2&clientId=68716&RQT=309&VName=PQD.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Gerlach, Christina Anna [Verfasser]. "Continuous intravenous infusion anaesthesia following two different protocols for immobilisation in impala (Aepyceros melampus) / Christina Anna Gerlach." Hannover : Bibliothek der Tierärztlichen Hochschule Hannover, 2016. http://d-nb.info/1124853855/34.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Книги з теми "Intravenous Infusion of Helixor®"

1

C, Prys-Roberts, Grundy Ernest, Yate Paul, and International Symposium on Intravenous Anaesthesia and Intensive Care Sedation (1991 : Cannes, France), eds. Focus on infusion: Intravenous anaesthesia. Current Medical Literature, 1991.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

L, Josephson Dianne, and Beaman Nina, eds. Intravenous infusion therapy for medical assistants. Thomson Delmar Learning, 2006.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Robert, Algozzine, and Lilly Deborah J, eds. Critical care intravenous infusion drug handbook. 3rd ed. Mosby/Elsevier, 2010.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Algozzine, Gary J. Critical care intravenous infusion drug handbook. 2nd ed. Mosby, 2005.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Lynn, Keegan, ed. Intravenous infusion therapy for nurses: Principles & practice. Delmar, 1999.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

1961-, Healing Guy, and Smith David 1944-, eds. Handbook of pre-clinical continuous intravenous infusion. Taylor & Francis, 2000.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Centre, Sunnybrook Medical, ed. The stability of morphine intravenous infusion solutions. s.n., 1985.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Inc, Biomedical Business International, ed. The Market for IV infusion devices. BBI, 1985.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Inc, Biomedical Business International, ed. The Market for IV infusion devices. 2nd ed. Biomedical Business International, 1986.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Phillips, Lynn Dianne. Manual of I.V. therapeutics: Evidence-based infusion therapy. 5th ed. F.A. Davis Co., 2010.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Частини книг з теми "Intravenous Infusion of Helixor®"

1

Eckmann, Maxim S., and Chad C. Parvus-Teichmann. "Intravenous Hydration Therapy." In Infusion Therapy. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-17478-1_16.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Scioli Montoto, Sebastian, and Maria Esperanza Ruiz. "Intravenous Bolus and Infusion." In The ADME Encyclopedia. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-84860-6_97.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Tranquilli, William J., Kurt A. Grimm, and Leigh A. Lamont. "Intravenous Constant Rate Infusion." In Pain Management, 2nd ed. Teton NewMedia, 2022. http://dx.doi.org/10.1201/9780429172717-29.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Scioli Montoto, Sebastian, and Maria Esperanza Ruiz. "Intravenous Bolus and Infusion." In The ADME Encyclopedia. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-51519-5_97-1.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Savva, Michalakis. "Intravenous Infusion and Flow Rate." In Pharmaceutical Calculations. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-20335-1_15.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Lapham, Robert. "Intravenous Therapy and Infusion Devices." In Drug Calculations for Nurses, 5th ed. Routledge, 2021. http://dx.doi.org/10.4324/9781003057062-12.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Foster, P. A. "Rapid Setting of Intravenous Infusion Rates." In Anaesthesia — Innovations in Management. Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-82392-3_19.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Kiiski, R., E. Fernandez, and G. Gutierrez. "Intravenous Potassium Infusion Reverses Skeletal Muscle Fatigue." In Advances in Experimental Medicine and Biology. Springer US, 1994. http://dx.doi.org/10.1007/978-1-4615-1875-4_100.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Chan, Matthew T. V. "Performance of Target-Controlled Infusion Systems." In Total Intravenous Anesthesia and Target Controlled Infusions. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-47609-4_9.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Viviand, Xavier, and Aurélie Bourgoin. "Target-Controlled Infusion in Children." In Advances in Modelling and Clinical Application of Intravenous Anaesthesia. Springer US, 2003. http://dx.doi.org/10.1007/978-1-4419-9192-8_15.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Intravenous Infusion of Helixor®"

1

Rele, Mayur, and Dipti Patil. "IoT Based Smart Intravenous Infusion Doing System." In 2023 International Conference on Artificial Intelligence Robotics, Signal and Image Processing (AIRoSIP). IEEE, 2023. https://doi.org/10.1109/airosip58759.2023.10874031.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Yapur Pizarro, Jhoseline Belen, Eynar Calle Viles, Mauricio Peredo Claros, Elías Chávez Jaldín, and Remmy Fuentes Telleria. "Smartwatch-Based IoT System for Continuous Intravenous Infusion Monitoring with Air Bubble Blockage." In 2024 3rd International Congress of Biomedical Engineering and Bioengineering (CIIBBI). IEEE, 2024. https://doi.org/10.1109/ciibbi63846.2024.10784881.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Gupta, Pulkit, Aditi Rao, Priya Chimurkar, and Prashant Kasambe. "An Automated IoT-Enabled Real-Time Intravenous Infusion cum Remote Patient Monitoring System." In 2025 International Conference on Emerging Smart Computing and Informatics (ESCI). IEEE, 2025. https://doi.org/10.1109/esci63694.2025.10988336.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Huang, Shizhen, and Fusheng Pan. "Design of Robust Intravenous Infusion Monitoring Device." In 2019 3rd International Conference on Electronic Information Technology and Computer Engineering (EITCE). IEEE, 2019. http://dx.doi.org/10.1109/eitce47263.2019.9095177.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Yang Zhang, Sanfeng Zhang, Yi Ji, and Guoxin Wu. "Intravenous infusion monitoring system based on WSN." In IET International Conference on Wireless Sensor Network 2010 (IET-WSN 2010). IET, 2010. http://dx.doi.org/10.1049/cp.2010.1024.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Alagundagi, Sourabh Suresh, Krupakar Pasala, and Manish Arora. "Opto-electronic system for intravenous infusion monitoring." In 2018 10th International Conference on Communication Systems & Networks (COMSNETS). IEEE, 2018. http://dx.doi.org/10.1109/comsnets.2018.8328296.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Chen, Fuh-Gwo, Jen-Ya Wang, Shian Chen, Sheng-Chung Tu, and Kuo-Yi Chen. "A Hang-and-Play Intravenous Infusion Monitoring System." In 2015 3rd International Conference on Applied Computing and Information Technology/2nd International Conference on Computational Science and Intelligence (ACIT-CSI). IEEE, 2015. http://dx.doi.org/10.1109/acit-csi.2015.57.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Almeida, Liliana, Nisha Abraham, Lucia Lauria, Michelle Barfoot, and Samantha Ali. "Patient experience with transition between intravenous infusion pumps." In ERS Congress 2024 abstracts. European Respiratory Society, 2024. http://dx.doi.org/10.1183/13993003.congress-2024.pa4313.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Sapatnekar, Malhar U., and Prakash M. Mainkar. "Design and Development of IOT Controlled Intravenous Infusion Device." In 2022 13th International Conference on Computing Communication and Networking Technologies (ICCCNT). IEEE, 2022. http://dx.doi.org/10.1109/icccnt54827.2022.9984327.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Bode, C., F. Schwarz, G. Schuler, R. Zimmermann, and W. Kubler. "INTRAVENOUS THROMBOLYTIC THERAPY WITH SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN ACTIVATOR IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643574.

Повний текст джерела
Анотація:
Seventeen patients with acute myocardial infarction were treated with heparin combined with intravenous single-chain urokinase-type plasminogen activator (scu-PA),obtained from transformed human kidney cells. 4 patients in group I and 13 patients in group II received a bolus of 4 mg and 7-5 mg followed by an infusion of 11 mg and 40.5 mg over 60 minutes, respectively. Thrombolysis was achieved in no patient of group I during intravenous infusion of scu-PA, however, upon subsequent intracoronary infusion of 250000 IE streptokinase, reperfusion could be established in two out of three patients.
Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Intravenous Infusion of Helixor®"

1

Murray, W. B. Provider Needs for Distributed Simulation Education System in Total Intravenous Anesthesia and Target Controlled Infusion. Defense Technical Information Center, 2009. http://dx.doi.org/10.21236/ada542258.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Murray, W. B. Provider Needs for Distributed Simulation Education System in Total Intravenous Anesthesia and Target Controlled Infusion. Defense Technical Information Center, 2008. http://dx.doi.org/10.21236/ada542263.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Chaiyabutr, Narongsak, Chollada Buranakarl, and Prapa Loypetjra. Effects of exogenous urea infusion on glucose metabolism in acute heat stressed swamp buffaloes. Chulalongkorn University, 1988. https://doi.org/10.58837/chula.res.1988.43.

Повний текст джерела
Анотація:
Effects of exogenous urea infusion on glucose metabolism in acute heat stressed swamp buffaloes. Five buffaloes kept in normal ambient temperature showed no significant changes in the heart rate, respiratory rate, packed cell volume, glucose turnover rate, glucose pool size, glucose clearance, glomerular filtration rate (GFR), effective renal plasma flow (ERPF), plasma concentration of electrolytes, protein and creatinine during intravenous infusion of urea for 4 h. The rate of urine flow, fractional urea excretion, urinary potassium excretion and osmolar clearance significantly decreased on t
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Yang, Wulan, aruhan Bai, yun Qing, and Na Ya. The efficacy and safety of intravenous infusion of Glycoprotein IIb/IIIa Inhibitors during stent implantation in cerebral infarction：A systematic review and a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. http://dx.doi.org/10.37766/inplasy2024.8.0128.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Chang, Ting-Yu, Chia-Te Chen, and Ching-Ju Fang. The efficacy and safety of intravenous infusion of Glycoprotein IIb/IIIa Inhibitors during stent implantation in cerebral infarction：A systematic review and a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. http://dx.doi.org/10.37766/inplasy2024.8.0129.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Також вас можуть зацікавити розширені добірки на тему "Intravenous Infusion of Helixor®" для конкретних типів джерел:
Статті в журналах Дисертації Книги
Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!

До бібліографії